By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
Aa
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: PTSD Patients in TXOG Focus Group Unanimously Report Symptom Relief Through Medical Cannabis
Share
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > Cannabis Press Releases > PTSD Patients in TXOG Focus Group Unanimously Report Symptom Relief Through Medical Cannabis
Cannabis Press Releases

PTSD Patients in TXOG Focus Group Unanimously Report Symptom Relief Through Medical Cannabis

Business Wire
Business Wire January 18, 2022
Updated 2022/05/30 at 7:51 AM
Share
SHARE

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from PTSD to evaluate symptom response, product preference and effects on supplemental pharmaceutical consumption

AUSTIN, Texas–(BUSINESS WIRE)–Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, today released results from its post-traumatic stress disorder (PTSD) focus group detailing the positive effects of medical cannabis use. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Cannabis Media & PR

- Advertisement -

Notably, 100% of the focus group participants reported they experienced relief from their symptoms associated with PTSD with TXOG’s product. This response reflects recent peer-reviewed studies from Wayne State University and the Federal University of Paraná that reported lower threat-related amygdala reactivity and suppressed anxiety in PTSD patients using medical cannabis.

“Many veterans in Texas and around the country face a much different enemy when they return home, one who is invisible but no less dangerous,” said Morris Denton, CEO of TXOG. “Medical cannabis plays a critical role in many of those veterans’ lives. TXOG stands committed to being an ally in that fight by doing whatever we can to not only help them find symptom relief, but to continue to drive the expansion of medical cannabis legislation that enhances accessibility for more veterans and other Texans suffering from PTSD.”

Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on prescriptions from their physicians. Patients overwhelmingly reported a quick product onset, with 77% and 62% of participants experiencing an onset within 30 minutes for gummies and tinctures, respectively. Eighty-five percent of participants also reported they were mostly or very satisfied with the product’s onset. Notably, more than 60% of participants reported a preference for TXOG’s gummy products, which are available in a 0:1 THC-only formulation as well as a 1:1 THC-to-CBD formulation.

Participants also unanimously reported a reduction in supplemental medication consumption after introducing TXOG’s medical cannabis products. All patients reported some level of reduction, with more than 30% of participants removing additional medications or pharmaceutical products completely from their treatment plans in collaboration with their prescribing physicians.

“I was previously prescribed high doses of clonazepam and was pretty much a zombie throughout my time taking it,” a study participant noted. “Once I found out that PTSD was added as a qualifying condition under the Compassionate Use Program, I met with a doctor and contacted Texas Original. This medicine has absolutely changed my life. Before incorporating medical cannabis into my treatment plan, I was afraid to leave my home. This medicine gives me the confidence to go out in public and interact with people. During and following the study, I even started going fishing and hiking more!”

TXOG’s gummy, tincture and lozenge products are available for statewide delivery at www.texasoriginal.com, at their dispensary in Austin, Texas, and through the company’s convenient pick-up locations in North Austin, Addison, Dallas, Fort Worth, Houston, San Antonio and Wichita Falls. To learn whether you or a loved one qualifies for medical cannabis, visit www.texasoriginal.com/patients.

- Advertisement -

About Texas Original Compassionate Cultivation

Texas Original Compassionate Cultivation (TXOG) is the leading licensed medical marijuana producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. TXOG is headquartered in Austin, with delivery throughout the entire state. For more information, visit www.texasoriginal.com.

Contacts

Emma Chase

[email protected]
512-917-4319

You Might Also Like

Proposed Settlement Reached in 2016 Class Action

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

IIPR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. and Encourages Investors to Contact the Firm

Creators of Muscle Milk Launch New Hemp Infused Sports Nutrition Brand GYM WEED in U.S. Market

TAGGED: Business Wire

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[wpforms id="4115329"]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Business Wire January 18, 2022
Share this Article
Twitter Reddit Email Copy Link
Previous Article Columbia Care Welcomes Derek Watson as Chief Financial Officer
Next Article Cresco Labs Announces Termination of Blair Wellness Acquisition

You Might Also Like

Proposed Settlement Reached in 2016 Class Action

June 24, 2022

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

June 24, 2022

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

June 23, 2022

IIPR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. and Encourages Investors to Contact the Firm

June 23, 2022

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?